Article Information
History
- August 7, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Seth D. Fortmann1,3,†,
- Michael J. Patton1,2,†,
- Blake F. Frey1,4,
- Cristiano P. Vieira3,
- Sivani B. Reddy6,
- Forest Huls2,
- Andrew Crouse2,
- Jason Floyd3,
- Ram Prasad3,
- Vidya Sagar Hanumanthu7,
- Sarah Sterrett8,
- Jeremy D. Zucker5,
- Peng Li9,
- Nathan Erdmann8,
- Paul A. Goepfert8,
- Amit Gaggar12,
- Maria B. Grant3,‡,* and
- Matthew Might2,‡,*
- 1Medical Scientist Training Program (MSTP), School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
- 2Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, Birmingham, AL, USA
- 3Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
- 4Department of Pathology, University of Alabama at Birmingham, Birmingham, AL
- 5Pacific Northwest National Laboratories, Biological Sciences Division, Richland, WA, USA
- 6Department of Dermatology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
- 7Department of Medicine and Microbiology, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, USA
- 8Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA
- 9School of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA
- 10Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA
- 11Department of Medicine, Division of Pulmonary, Allergy and Critical Care, University of Alabama at Birmingham, Birmingham, AL, USA
- 12Department of Medicine, Division of Pulmonary, Allergy and Critical Care, University of Alabama at Birmingham, Birmingham, AL, USA
- ↵*Corresponding Authors. email: might{at}uab.edu
Posted August 07, 2021.
Megakaryocytes are a Novel SARS-CoV-2 Infection Target and Risk Factor for Mortality and Multi-Organ Failure
